Cholesterol rethink for high-risk patients.
Publication
, Journal Article
Published in: Med Lett Drugs Ther
May 10, 2004
Duke Scholars
Published In
Med Lett Drugs Ther
ISSN
0025-732X
Publication Date
May 10, 2004
Volume
46
Issue
1182
Start / End Page
37 / 39
Location
United States
Related Subject Headings
- Risk Factors
- Pharmacology & Pharmacy
- Muscular Diseases
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Coronary Disease
- Clinical Trials as Topic
- Cholesterol, LDL
- Acute Disease
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cholesterol rethink for high-risk patients. (2004). Med Lett Drugs Ther, 46(1182), 37–39.
“Cholesterol rethink for high-risk patients.” Med Lett Drugs Ther 46, no. 1182 (May 10, 2004): 37–39.
Cholesterol rethink for high-risk patients. Med Lett Drugs Ther. 2004 May 10;46(1182):37–9.
“Cholesterol rethink for high-risk patients.” Med Lett Drugs Ther, vol. 46, no. 1182, May 2004, pp. 37–39.
Cholesterol rethink for high-risk patients. Med Lett Drugs Ther. 2004 May 10;46(1182):37–39.
Published In
Med Lett Drugs Ther
ISSN
0025-732X
Publication Date
May 10, 2004
Volume
46
Issue
1182
Start / End Page
37 / 39
Location
United States
Related Subject Headings
- Risk Factors
- Pharmacology & Pharmacy
- Muscular Diseases
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Coronary Disease
- Clinical Trials as Topic
- Cholesterol, LDL
- Acute Disease
- 3214 Pharmacology and pharmaceutical sciences